カテゴリ： QYResearch, 世界, 消費財/食品

KRAS検査の世界市場2025年：KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他

■ 英語タイトル：Global KRAS Tests Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8029）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8029
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[KRAS検査の世界市場2025年：KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はKRAS検査のグローバル市場について調査・分析し、世界のKRAS検査市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他）、用途別セグメント分析（大腸がん（CRC）、肺がん）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Qiagen NV、F. Hoffmann-La Roche Ltd,、Thermo Fisher Scientific Inc、Takara Bio Inc、Panagene Inc、Amoy Diagnostics Co Ltdなどが含まれています。KRAS検査のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、KRAS検査市場規模を算出する際に考慮しました。

・KRAS検査市場の概要
- 製品の定義
- KRAS検査の種類別セグメント
- 世界のKRAS検査市場規模：タイプ別分析（KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他）
- KRAS検査の用途別セグメント
- 世界のKRAS検査市場規模：用途別分析（大腸がん（CRC）、肺がん）
- 世界のKRAS検査市場規模予測（2020年-2031年）
- KRAS検査の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- KRAS検査市場の競争状況およびトレンド

・KRAS検査の地域別市場規模
- 北米のKRAS検査市場規模（2020年-2031年）
- 米国のKRAS検査市場規模（2020年-2031年）
- ヨーロッパのKRAS検査市場規模（2020年-2031年）
- アジア太平洋のKRAS検査市場規模（2020年-2031年）
- 中国のKRAS検査市場規模（2020年-2031年）
- 日本のKRAS検査市場規模（2020年-2031年）
- 韓国のKRAS検査市場規模（2020年-2031年）
- インドのKRAS検査市場規模（2020年-2031年）
- オーストラリアのKRAS検査市場規模（2020年-2031年）
- 中南米のKRAS検査市場規模（2020年-2031年）
- 中東・アフリカのKRAS検査市場規模（2020年-2031年）

・種類別セグメント：KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他
- 世界のKRAS検査のタイプ別販売量（2020年-2025年）
- 世界のKRAS検査のタイプ別売上（2020年-2025年）
- 世界のKRAS検査のタイプ別価格

・用途別セグメント：大腸がん（CRC）、肺がん
- 世界のKRAS検査の用途別販売量（2020年-2025年）
- 世界のKRAS検査の用途別売上（2020年-2025年）
- 世界のKRAS検査の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Qiagen NV、F. Hoffmann-La Roche Ltd,、Thermo Fisher Scientific Inc、Takara Bio Inc、Panagene Inc、Amoy Diagnostics Co Ltd

・産業チェーンと販売チャネルの分析
- KRAS検査産業チェーン分析
- KRAS検査の主要原材料
- KRAS検査の販売チャネル
- KRAS検査のディストリビューター
- KRAS検査の主要顧客

・KRAS検査市場ダイナミクス
- KRAS検査の業界動向
- KRAS検査市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Kirsten Rat Sarcoma(KRAS)is a downstream signalling molecule in the EGFR cellular pathway with roles in cell growth and proliferation
Highlights
The global KRAS Tests market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for KRAS Tests is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for KRAS Tests is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of KRAS Tests include Qiagen NV, F. Hoffmann-La Roche Ltd,, Thermo Fisher Scientific Inc, Takara Bio Inc, Panagene Inc and Amoy Diagnostics Co Ltd, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for KRAS Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding KRAS Tests.
The KRAS Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global KRAS Tests market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the KRAS Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Qiagen NV
F. Hoffmann-La Roche Ltd,
Thermo Fisher Scientific Inc
Takara Bio Inc
Panagene Inc
Amoy Diagnostics Co Ltd
Segment by Type
KRAS Sanger sequencing Tests
KRAS Nucleic Acid Amplification Tests (NAAT)
KRAS Other Tests
Segment by Application
Colorectal Cancer (CRC)
Lung Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of KRAS Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of KRAS Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 KRAS Tests Market Overview
1.1 Product Overview and Scope of KRAS Tests
1.2 KRAS Tests Segment by Type
1.2.1 Global KRAS Tests Market Value Comparison by Type (2025-2031)
1.2.2 KRAS Sanger sequencing Tests
1.2.3 KRAS Nucleic Acid Amplification Tests (NAAT)
1.2.4 KRAS Other Tests
1.3 KRAS Tests Segment by Application
1.3.1 Global KRAS Tests Market Value by Application: (2025-2031)
1.3.2 Colorectal Cancer (CRC)
1.3.3 Lung Cancer
1.4 Global KRAS Tests Market Size Estimates and Forecasts
1.4.1 Global KRAS Tests Revenue 2020-2031
1.4.2 Global KRAS Tests Sales 2020-2031
1.4.3 Global KRAS Tests Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 KRAS Tests Market Competition by Manufacturers
2.1 Global KRAS Tests Sales Market Share by Manufacturers (2020-2025)
2.2 Global KRAS Tests Revenue Market Share by Manufacturers (2020-2025)
2.3 Global KRAS Tests Average Price by Manufacturers (2020-2025)
2.4 Global KRAS Tests Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of KRAS Tests, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of KRAS Tests, Product Type & Application
2.7 KRAS Tests Market Competitive Situation and Trends
2.7.1 KRAS Tests Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest KRAS Tests Players Market Share by Revenue
2.7.3 Global KRAS Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 KRAS Tests Retrospective Market Scenario by Region
3.1 Global KRAS Tests Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global KRAS Tests Global KRAS Tests Sales by Region: 2020-2031
3.2.1 Global KRAS Tests Sales by Region: 2020-2025
3.2.2 Global KRAS Tests Sales by Region: 2026-2031
3.3 Global KRAS Tests Global KRAS Tests Revenue by Region: 2020-2031
3.3.1 Global KRAS Tests Revenue by Region: 2020-2025
3.3.2 Global KRAS Tests Revenue by Region: 2026-2031
3.4 North America KRAS Tests Market Facts & Figures by Country
3.4.1 North America KRAS Tests Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America KRAS Tests Sales by Country (2020-2031)
3.4.3 North America KRAS Tests Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe KRAS Tests Market Facts & Figures by Country
3.5.1 Europe KRAS Tests Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe KRAS Tests Sales by Country (2020-2031)
3.5.3 Europe KRAS Tests Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific KRAS Tests Market Facts & Figures by Country
3.6.1 Asia Pacific KRAS Tests Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific KRAS Tests Sales by Country (2020-2031)
3.6.3 Asia Pacific KRAS Tests Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America KRAS Tests Market Facts & Figures by Country
3.7.1 Latin America KRAS Tests Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America KRAS Tests Sales by Country (2020-2031)
3.7.3 Latin America KRAS Tests Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa KRAS Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa KRAS Tests Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa KRAS Tests Sales by Country (2020-2031)
3.8.3 Middle East and Africa KRAS Tests Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global KRAS Tests Sales by Type (2020-2031)
4.1.1 Global KRAS Tests Sales by Type (2020-2025)
4.1.2 Global KRAS Tests Sales by Type (2026-2031)
4.1.3 Global KRAS Tests Sales Market Share by Type (2020-2031)
4.2 Global KRAS Tests Revenue by Type (2020-2031)
4.2.1 Global KRAS Tests Revenue by Type (2020-2025)
4.2.2 Global KRAS Tests Revenue by Type (2026-2031)
4.2.3 Global KRAS Tests Revenue Market Share by Type (2020-2031)
4.3 Global KRAS Tests Price by Type (2020-2031)
5 Segment by Application
5.1 Global KRAS Tests Sales by Application (2020-2031)
5.1.1 Global KRAS Tests Sales by Application (2020-2025)
5.1.2 Global KRAS Tests Sales by Application (2026-2031)
5.1.3 Global KRAS Tests Sales Market Share by Application (2020-2031)
5.2 Global KRAS Tests Revenue by Application (2020-2031)
5.2.1 Global KRAS Tests Revenue by Application (2020-2025)
5.2.2 Global KRAS Tests Revenue by Application (2026-2031)
5.2.3 Global KRAS Tests Revenue Market Share by Application (2020-2031)
5.3 Global KRAS Tests Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Qiagen NV
6.1.1 Qiagen NV Corporation Information
6.1.2 Qiagen NV Description and Business Overview
6.1.3 Qiagen NV KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Qiagen NV KRAS Tests Product Portfolio
6.1.5 Qiagen NV Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd,
6.2.1 F. Hoffmann-La Roche Ltd, Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd, Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd, KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.2.4 F. Hoffmann-La Roche Ltd, KRAS Tests Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd, Recent Developments/Updates
6.3 Thermo Fisher Scientific Inc
6.3.1 Thermo Fisher Scientific Inc Corporation Information
6.3.2 Thermo Fisher Scientific Inc Description and Business Overview
6.3.3 Thermo Fisher Scientific Inc KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Thermo Fisher Scientific Inc KRAS Tests Product Portfolio
6.3.5 Thermo Fisher Scientific Inc Recent Developments/Updates
6.4 Takara Bio Inc
6.4.1 Takara Bio Inc Corporation Information
6.4.2 Takara Bio Inc Description and Business Overview
6.4.3 Takara Bio Inc KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takara Bio Inc KRAS Tests Product Portfolio
6.4.5 Takara Bio Inc Recent Developments/Updates
6.5 Panagene Inc
6.5.1 Panagene Inc Corporation Information
6.5.2 Panagene Inc Description and Business Overview
6.5.3 Panagene Inc KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Panagene Inc KRAS Tests Product Portfolio
6.5.5 Panagene Inc Recent Developments/Updates
6.6 Amoy Diagnostics Co Ltd
6.6.1 Amoy Diagnostics Co Ltd Corporation Information
6.6.2 Amoy Diagnostics Co Ltd Description and Business Overview
6.6.3 Amoy Diagnostics Co Ltd KRAS Tests Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amoy Diagnostics Co Ltd KRAS Tests Product Portfolio
6.6.5 Amoy Diagnostics Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 KRAS Tests Industry Chain Analysis
7.2 KRAS Tests Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 KRAS Tests Production Mode & Process
7.4 KRAS Tests Sales and Marketing
7.4.1 KRAS Tests Sales Channels
7.4.2 KRAS Tests Distributors
7.5 KRAS Tests Customers
8 KRAS Tests Market Dynamics
8.1 KRAS Tests Industry Trends
8.2 KRAS Tests Market Drivers
8.3 KRAS Tests Market Challenges
8.4 KRAS Tests Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global KRAS Tests Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global KRAS Tests Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global KRAS Tests Market Competitive Situation by Manufacturers in 2024
Table 4. Global KRAS Tests Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global KRAS Tests Sales Market Share by Manufacturers (2020-2025)
Table 6. Global KRAS Tests Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global KRAS Tests Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market KRAS Tests Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of KRAS Tests, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of KRAS Tests, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of KRAS Tests, Product Type & Application
Table 12. Global Key Manufacturers of KRAS Tests, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global KRAS Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KRAS Tests as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global KRAS Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global KRAS Tests Sales by Region (2020-2025) & (K Units)
Table 18. Global KRAS Tests Sales Market Share by Region (2020-2025)
Table 19. Global KRAS Tests Sales by Region (2026-2031) & (K Units)
Table 20. Global KRAS Tests Sales Market Share by Region (2026-2031)
Table 21. Global KRAS Tests Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global KRAS Tests Revenue Market Share by Region (2020-2025)
Table 23. Global KRAS Tests Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global KRAS Tests Revenue Market Share by Region (2026-2031)
Table 25. North America KRAS Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America KRAS Tests Sales by Country (2020-2025) & (K Units)
Table 27. North America KRAS Tests Sales by Country (2026-2031) & (K Units)
Table 28. North America KRAS Tests Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America KRAS Tests Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe KRAS Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe KRAS Tests Sales by Country (2020-2025) & (K Units)
Table 32. Europe KRAS Tests Sales by Country (2026-2031) & (K Units)
Table 33. Europe KRAS Tests Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe KRAS Tests Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific KRAS Tests Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific KRAS Tests Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific KRAS Tests Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific KRAS Tests Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific KRAS Tests Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America KRAS Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America KRAS Tests Sales by Country (2020-2025) & (K Units)
Table 42. Latin America KRAS Tests Sales by Country (2026-2031) & (K Units)
Table 43. Latin America KRAS Tests Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America KRAS Tests Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa KRAS Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa KRAS Tests Sales by Country (2020-2025) & (K Units)
Table 47. Middle East & Africa KRAS Tests Sales by Country (2026-2031) & (K Units)
Table 48. Middle East & Africa KRAS Tests Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa KRAS Tests Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global KRAS Tests Sales (K Units) by Type (2020-2025)
Table 51. Global KRAS Tests Sales (K Units) by Type (2026-2031)
Table 52. Global KRAS Tests Sales Market Share by Type (2020-2025)
Table 53. Global KRAS Tests Sales Market Share by Type (2026-2031)
Table 54. Global KRAS Tests Revenue (US$ Million) by Type (2020-2025)
Table 55. Global KRAS Tests Revenue (US$ Million) by Type (2026-2031)
Table 56. Global KRAS Tests Revenue Market Share by Type (2020-2025)
Table 57. Global KRAS Tests Revenue Market Share by Type (2026-2031)
Table 58. Global KRAS Tests Price (US$/Unit) by Type (2020-2025)
Table 59. Global KRAS Tests Price (US$/Unit) by Type (2026-2031)
Table 60. Global KRAS Tests Sales (K Units) by Application (2020-2025)
Table 61. Global KRAS Tests Sales (K Units) by Application (2026-2031)
Table 62. Global KRAS Tests Sales Market Share by Application (2020-2025)
Table 63. Global KRAS Tests Sales Market Share by Application (2026-2031)
Table 64. Global KRAS Tests Revenue (US$ Million) by Application (2020-2025)
Table 65. Global KRAS Tests Revenue (US$ Million) by Application (2026-2031)
Table 66. Global KRAS Tests Revenue Market Share by Application (2020-2025)
Table 67. Global KRAS Tests Revenue Market Share by Application (2026-2031)
Table 68. Global KRAS Tests Price (US$/Unit) by Application (2020-2025)
Table 69. Global KRAS Tests Price (US$/Unit) by Application (2026-2031)
Table 70. Qiagen NV Corporation Information
Table 71. Qiagen NV Description and Business Overview
Table 72. Qiagen NV KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Qiagen NV KRAS Tests Product
Table 74. Qiagen NV Recent Developments/Updates
Table 75. F. Hoffmann-La Roche Ltd, Corporation Information
Table 76. F. Hoffmann-La Roche Ltd, Description and Business Overview
Table 77. F. Hoffmann-La Roche Ltd, KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. F. Hoffmann-La Roche Ltd, KRAS Tests Product
Table 79. F. Hoffmann-La Roche Ltd, Recent Developments/Updates
Table 80. Thermo Fisher Scientific Inc Corporation Information
Table 81. Thermo Fisher Scientific Inc Description and Business Overview
Table 82. Thermo Fisher Scientific Inc KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Inc KRAS Tests Product
Table 84. Thermo Fisher Scientific Inc Recent Developments/Updates
Table 85. Takara Bio Inc Corporation Information
Table 86. Takara Bio Inc Description and Business Overview
Table 87. Takara Bio Inc KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takara Bio Inc KRAS Tests Product
Table 89. Takara Bio Inc Recent Developments/Updates
Table 90. Panagene Inc Corporation Information
Table 91. Panagene Inc Description and Business Overview
Table 92. Panagene Inc KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Panagene Inc KRAS Tests Product
Table 94. Panagene Inc Recent Developments/Updates
Table 95. Amoy Diagnostics Co Ltd Corporation Information
Table 96. Amoy Diagnostics Co Ltd Description and Business Overview
Table 97. Amoy Diagnostics Co Ltd KRAS Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Amoy Diagnostics Co Ltd KRAS Tests Product
Table 99. Amoy Diagnostics Co Ltd Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. KRAS Tests Distributors List
Table 103. KRAS Tests Customers List
Table 104. KRAS Tests Market Trends
Table 105. KRAS Tests Market Drivers
Table 106. KRAS Tests Market Challenges
Table 107. KRAS Tests Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of KRAS Tests
Figure 2. Global KRAS Tests Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global KRAS Tests Market Share by Type in 2024 & 2031
Figure 4. KRAS Sanger sequencing Tests Product Picture
Figure 5. KRAS Nucleic Acid Amplification Tests (NAAT) Product Picture
Figure 6. KRAS Other Tests Product Picture
Figure 7. Global KRAS Tests Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 8. Global KRAS Tests Market Share by Application in 2024 & 2031
Figure 9. Colorectal Cancer (CRC)
Figure 10. Lung Cancer
Figure 11. Global KRAS Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global KRAS Tests Market Size (2020-2031) & (US$ Million)
Figure 13. Global KRAS Tests Sales (2020-2031) & (K Units)
Figure 14. Global KRAS Tests Average Price (US$/Unit) & (2020-2031)
Figure 15. KRAS Tests Report Years Considered
Figure 16. KRAS Tests Sales Share by Manufacturers in 2024
Figure 17. Global KRAS Tests Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest KRAS Tests Players: Market Share by Revenue in 2024
Figure 19. KRAS Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 20. Global KRAS Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America KRAS Tests Sales Market Share by Country (2020-2031)
Figure 22. North America KRAS Tests Revenue Market Share by Country (2020-2031)
Figure 23. United States KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe KRAS Tests Sales Market Share by Country (2020-2031)
Figure 26. Europe KRAS Tests Revenue Market Share by Country (2020-2031)
Figure 27. Germany KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific KRAS Tests Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific KRAS Tests Revenue Market Share by Region (2020-2031)
Figure 34. China KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America KRAS Tests Sales Market Share by Country (2020-2031)
Figure 44. Latin America KRAS Tests Revenue Market Share by Country (2020-2031)
Figure 45. Mexico KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa KRAS Tests Sales Market Share by Country (2020-2031)
Figure 49. Middle East & Africa KRAS Tests Revenue Market Share by Country (2020-2031)
Figure 50. Turkey KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE KRAS Tests Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of KRAS Tests by Type (2020-2031)
Figure 54. Global Revenue Market Share of KRAS Tests by Type (2020-2031)
Figure 55. Global KRAS Tests Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of KRAS Tests by Application (2020-2031)
Figure 57. Global Revenue Market Share of KRAS Tests by Application (2020-2031)
Figure 58. Global KRAS Tests Price (US$/Unit) by Application (2020-2031)
Figure 59. KRAS Tests Value Chain
Figure 60. KRAS Tests Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

※参考情報

KRAS検査とは、がん治療の最適化において重要な役割を果たす遺伝子検査の一つです。KRAS遺伝子は、細胞の増殖や分化、細胞死などに関与するたんぱく質をコードしており、主にがんの進行や治療に対して敏感な指標として利用されています。KRAS遺伝子に異常が生じると、がん細胞は異常な増殖を示し、治療の抵抗性が高まることが知られています。以下では、KRAS検査の概念、特徴、種類、用途、関連技術について詳述します。

まず、KRAS検査の定義ですが、これはKRAS遺伝子の変異を特定するための検査です。具体的には、KRAS遺伝子内の特定のヌクレオチドが変化することによって、正常な細胞の機能を阻害する亜種が生じます。この変異が抗がん剤に対する感受性へ与える影響を解析し、個々の患者に最適な治療法を選択する手助けをします。

次にKRAS検査の特徴について述べます。KRAS遺伝子の変異は、特に膵臓癌や大腸癌、肺癌など、いくつかの固形がんにおいて高率に観察されます。これらのがんにおいて、KRAS変異が確認されると、標準的な治療に対して抵抗性を示すことが多く、患者の予後に悪影響を及ぼすことが知られています。そのため、KRAS遺伝子が持つ情報は、個々のがん患者において非常に重要です。

KRAS検査にはいくつかの種類があります。一般的に利用されるのは、直接的なDNAシーケンシングによる変異解析や、PCR（ポリメラーゼ連鎖反応）を用いた変異の検出方法です。これにより、特に注目される変異箇所（例えばG12C、G12D、G13D）を特定することが可能です。また、次世代シーケンシング（NGS）技術の導入により、より広範な遺伝子解析も行えるようになりました。

KRAS検査の主な用途は、抗がん剤の投与に関する意思決定を行うための情報提供です。具体的には、EGFR（上皮成長因子受容体）阻害剤などの治療がKRAS変異のある患者には効果がないことがわかっており、これによって無駄な治療を避けることができます。さらに、KRAS変異を持つ患者に特化した新しい治療薬の開発が進んでおり、これも検査の重要な意義の一つです。

関連技術としては、バイオマーカーの研究や新規治療法の開発が挙げられます。KRAS遺伝子変異を標的にした新しい薬剤の開発が進んでおり、具体的には、KRAS G12C変異に対して特異的に作用する薬剤などが臨床試験で評価されています。また、コンパニオン診断としてKRAS検査が位置付けられており、特定の治療法が有効であることを確認するための手段として必須です。

KRAS検査は急速に進化しており、最新の分子生物学や遺伝子工学の成果が注入されています。これにより、より高精度で迅速な診断が可能となり、患者の個別化医療を進める重要な鍵となっています。特に、治療法の選択肢が増加する中で、患者にとって最も効果的な戦略を選ぶための基盤となるのです。

これからのがん治療において、KRAS検査はますます重要な役割を果たしていくと考えられています。科学技術の進展によって新たな診断法や治療法が開発され、KRAS変異に対する理解が深まることで、患者にとってより良い治療成果が期待されます。個別化医療が進む中で、KRAS検査は今後のがん治療における基盤となる重要な要素となり続けるでしょう。

このように、KRAS検査はがん治療において欠かせない検査であり、がん患者の治療方針を決定する上で非常に重要な役割を果たしています。今後も、さらなる研究や技術の進歩によって、KRAS検査の利用が拡大し、がん治療の質が向上することが期待されます。患者一人ひとりに対する最適な治療を実現するために、KRAS検査は今後ますます重要性を増していくでしょう。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 核酸増幅検査（NAAT）の世界市場2023-2032：機会分析・産業予測
  • 世界の肺マーカー市場予測（2024年-2032年）：癌種類別（非小細胞肺癌（NSCLC）、小細胞肺癌（SCLC））、マーカー種類別（EGFR、EML4-ALK、KRAS、BRAF、その他）、エンドユーザー別（病院、診断ラボ、その他）、地域別
  • 膣用パネル検査の世界市場2025-2031：直接分子DNAプローブ、分子核酸増幅検査(NAAT)
  • がん診断の世界市場2022～2031：検査種類別、エンドユーザー別
  • ボトリチス検査の世界市場2025年：ラテラルフロー解析、蛍光酵素免疫測定法、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8029 )"KRAS検査の世界市場2025年：KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他" (英文：Global KRAS Tests Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。